Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate for Gaucher disease ...

The research teams at LV Prasad Eye Institute under the Centre for Ocular Regeneration (CORE) at the Brien Holden Research Centre, organized the second edition of the ‘Future is Here’.

The SNU BioTalk 2025 an International Conference, themed "Symphony of Cellular Signals in Metabolism and Immune Response," ...

Plant and soil sciences doctoral student Charanpreet Kaur researches environmentally friendly solutions for turfgrass ...

Photonics West, the premier event for the photonics community takes place on January 26 to 29, 2025 in San Francisco’s Moscone Center. Attendees will gain unparalleled access to industry-leading ...

Trained immunity, a modification of cells in the innate immune system, may represent a new way of protecting poultry from infectious diseases. In a recent review article, researchers from Japan ...

Perthera, a leader in precision oncology, will present follow-on research and validation of the world's first AI-driven chemo ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has extended its 13-year relationship with Tigermed, a leading global provider of ...

Nivolumab plus chemotherapy improved long-term survival in Chinese patients with advanced gastric, GEJ, or esophageal cancer.

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in Chinese patients with advanced gastric, gastroesophageal junction, and ...

Developer-Realtor Keith Kite has been bullish on higher-speed rail since 2013. He has built some neat hotels in Indian River ...

Dénia will be the setting for the presentation of the book El tractat de l'scaldat del raïm i la pansa de lleixiu: ...